Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis

Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis

Bibliographic Details
Main Authors:	Scott Heysell, Stellah Mpgama
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	The Lancet Microbe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666524720300343

Similar Items

Treatment of isoniazid-resistant pulmonary tuberculosis
by: Lim Si, et al.
Published: (2008-01-01)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
by: Byung Woo Jhun, M.D., et al.
Published: (2020-01-01)

Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
by: Lijie Zhang, et al.
Published: (2024-01-01)

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.

Isoniazid and Pulmonary Fibrosis
by: Chae Uk Chung, et al.
Published: (2015-01-01)

The Relationship Between The Blood Concentration Of Isoniazid, Rifampicin, Pyrazinamide And The Treatment Outcomes Of Pulmonary Tuberculosis Patients
by: Mahjoub, Abdallah Abdallah
Published: (2017)

Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis
by: Bibie N Said, et al.
Published: (2021-01-01)

ISONIAZID - MONORESISTANT TUBERCULOSIS IN BULGARIA
by: Stanislava Yordanova, et al.
Published: (2020-05-01)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
by: Konstantina Chachlioutaki, et al.
Published: (2020-05-01)

Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis
by: Brian Cody Adkinson, et al.
Published: (2020-11-01)

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
by: Renata Báez-Saldaña, et al.
Published: (2016-01-01)

The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India.
by: Dorai Deepa, et al.
Published: (2013-01-01)

Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
by: Shreshth Khanna, et al.
Published: (2023-06-01)

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.
by: Raymund Dantes, et al.
Published: (2012-01-01)

Is a 6-month Treatment for Isoniazid-resistant Tuberculosis Effective?
by: A. I. Kulizhskaya, et al.
Published: (2022-03-01)

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: A. V. Zаkhаrov, et al.
Published: (2017-06-01)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)

Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
by: Leeberk Raja Inbaraj, et al.
Published: (2023-06-01)

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis
by: Mônica C. Façanha, et al.

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
by: Lisa Nkatha Micheni, et al.
Published: (2021-01-01)

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.
by: Margaretha Sariko, et al.
Published: (2017-01-01)

The efficacy of the combination drug of hydroxymethylquinoxalinedioxide + isoniazid lyophilisate in the treatment of bronchial tuberculosis
by: A. A. Stаrshinovа
Published: (2019-05-01)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
by: Muluwork Getahun, et al.
Published: (2022-01-01)

The tuberculosis prodrug isoniazid bound to activating peroxidases.
by: Metcalfe, C, et al.
Published: (2008)

CURRENT APPROACHES TO CONTROL OF ISONIAZID-RESISTANT TUBERCULOSIS
by: Vladimir Milanov, et al.
Published: (2022-10-01)

The use of isoniazid syrup for the prevention of tuberculosis in children.
by: Liliya Todoriko, et al.
Published: (2019-09-01)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
by: Chih-Cheng Lai, et al.
Published: (2011-09-01)

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012-01-01)

The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
by: Usanee Ungcharoen, et al.
Published: (2020-12-01)

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand
by: Ajala Prommi, et al.
Published: (2024-03-01)

High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin
by: Mahamadou Bassirou Souleymane, et al.
Published: (2023-08-01)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis.
by: Dhiraj Kumar Singh, et al.
Published: (2021-08-01)

Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events
by: Marwa Bachir, et al.
Published: (2021-06-01)

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
by: Joaquim Trigo Marquês, et al.
Published: (2022-05-01)

Isoniazid resistance profile in rifampicin resistant Mycobacterium tuberculosis
by: Naomee Shareef, et al.
Published: (2023-09-01)

Isoniazid-induced thrombocytopenia in a patient with ocular tuberculosis
by: Preeti Gupta, et al.
Published: (2019-01-01)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
by: Elsje Pienaar, et al.
Published: (2018-01-01)

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis
by: Fabian Lentz, et al.
Published: (2018-04-01)

Molecular characterization of Mycobacterium tuberculosis strains resistant to isoniazid
by: Salma Smaoui, et al.
Published: (2016-01-01)